Hyundai Motor Group posts a record U.S. sales month for January, fueled by a 66% surge in hybrid vehicle deliveries. The milestone comes despite headwinds for electric models following IRA tax credit changes.
Investment bank Evercore capped a record year with strong Q4 results, announcing a dividend hike and completing a major share buyback. While the numbers underscore operational strength, analysts debate whether the stock's premium valuation adequately prices in cyclical risks.
Sotera Health's stock presents a valuation conundrum, with discounted cash flow analysis suggesting a 37% upside while its sky-high P/E ratio signals overvaluation. As investors reassess biotech and pharmaceutical services firms, the debate intensifies around SHC's true worth.
German factory orders soared 7.8% in December, the strongest monthly gain in two years and far exceeding analyst forecasts, sparking cautious optimism that the industrial heart of Europe may be stabilizing.
The German government, via KfW, is set to become a direct shareholder in TenneT Germany with a 25.1% stake, bolstering the grid operator's capital for critical energy transition investments. The deal is slated for completion by mid-2026.
Despite a decade of closures, major banks are reinvesting in branches—not as transaction centers, but as data-driven advisory hubs. Advanced analytics is key to personalizing service, improving profitability, and serving community needs in an increasingly digital world.
Phillips 66 reported robust fourth-quarter and full-year 2025 results, driven by refining efficiency and midstream growth. CEO Mark Lashier outlined a strategic path focused on cost reduction, portfolio optimization, and disciplined capital returns to shareholders.
Despite facing a challenging macroeconomic climate marked by reduced restaurant visits and a government shutdown, Performance Food Group (PFGC) reported fiscal Q2 2026 results in line with its guidance, showcasing growth in sales and profitability while prioritizing debt reduction.
As Russia intensifies winter attacks on Ukraine's energy infrastructure, negotiators from both sides, with U.S. envoys present, continue high-stakes talks seeking a path to end the nearly four-year war, despite a reported surge in civilian casualties.
Shareholders of Atmos Energy (NYSE: ATO) have delivered a strong vote of confidence, approving all eight proposals at the annual meeting. The sweeping approvals include the election of the full board, ratification of the auditor, and key governance amendments, signaling smooth sailing for the natural gas utility's leadership and strategic direction.
Consumer finance provider Regional Management (NYSE: RM) reported robust fourth-quarter and full-year 2025 results, fueled by portfolio expansion and improved credit metrics. The company's leadership outlined an ambitious 2026 roadmap centered on branch network growth, a strategic push into auto-secured lending, and sustained tech investment.
The New York Times Company reported robust digital subscriber and revenue gains for 2025, driven by its subscription-first strategy. While navigating a challenging media landscape, executives outlined ambitious plans to scale video content and leverage AI, even as costs rise.
Prudential Financial's solid 2025 results were overshadowed by a misconduct scandal in its Japan unit, prompting a voluntary 90-day sales halt and a projected $300-$350 million earnings impact for 2026. CEO Andy Sullivan vowed to restore trust as the insurer navigates regulatory scrutiny and revamps its sales practices.
Siemens Healthineers reported a resilient start to fiscal 2026, with strong performance in its imaging and precision therapy divisions offsetting a significant downturn in its diagnostics business in China, prompting a strategic reassessment of its operations in the key Asian market.
The Swiss pharma giant reported robust 2025 results, hitting a key profitability goal early. While facing near-term pressure from U.S. generic competition, CEO Vas Narasimhan outlined a strategy anchored by a portfolio of growth brands and a promising late-stage pipeline.
With a $7 billion acquisition and a pipeline focused on convenience, Pfizer is mounting a strategic challenge to Eli Lilly and Novo Nordisk's weight-loss drug stronghold, though commercial impact remains years away.
As surging data center demand electrifies the traditionally steady utility sector, NextEra Energy and Dominion Energy emerge as key infrastructure players with compelling total return prospects.
The British government announces a collaborative initiative with Microsoft and leading experts to develop a national framework for detecting and assessing deepfake content, responding to a surge in AI-generated fraud and abuse.
As investors navigate a complex economic landscape, Costco Wholesale continues to demonstrate remarkable resilience. However, its lofty valuation relative to peers prompts a critical question about its current investment appeal.
Healthcare distribution giant McKesson reported robust fiscal third-quarter results, with double-digit growth in revenue and earnings. The company raised its full-year guidance, citing strength in its oncology services and the booming distribution of GLP-1 medications.
